Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
    • China ESG Focus
  • Fast News
  • Expert Corner
  • Audio/Video
  • IPO
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
    • China ESG Focus
  • Fast News
  • Expert Corner
  • Audio/Video
  • IPO
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
Stories About 2616.HK
111 does healthcare

BRIEF: CStone raises $134 million in share placement at 7% discount

2026-04-15
The share price fell nearly 40% in a week after this drugs company was dropped from a scheme allowing mainland investors to trade Hong Kong-listed stocks.

Stock disconnect triggers investor exodus from CStone Pharma

2024-03-14
CStone Pharmaceuticals announced Wednesday that it has entered into a strategic partnership and exclusive licensing agreement with Shenyang Sunshine Pharmaceutical, a subsidiary of 3SBio Inc., for anti-PD-1 antibody Nofazinlimab in mainland China.

FAST NEWS: CStone licenses PD-1 cancer drug to 3SBio for China

2023-11-02
CStone Pharmaceuticals on Tuesday announced that its CEO Jason Yang plans to buy up to HK$5 million worth of the company’s shares in the open market over the next six months.

FAST NEWS: CStone says CEO to boost company holdings

2023-10-04

FAST NEWS: CStone drug approved for treatment of advanced non-small cell lung cancer

2023-06-27

CStone breaks up with drugs partner as U.S. rollout stalls

2023-05-18

Recent Articles

Dongshan Precision launches Hong Kong IPO
October 20, 2026

Dongshan Precision launches $1.3 billion Hong Kong IPO

2384.HK
002384.SHE
October 20, 2026

Microintelligence launches $100 million Hong Kong IPO

3275.HK
October 20, 2026

Infinigence takes its AI chip-translator pitch to Hong Kong investors

October 20, 2026

TCL Electronics posts revenue, profit growth in first three quarters

1070.HK
October 20, 2026

Gon Tech taps high-grade industrial gases to accelerate growth

2768.HK
002768.SHE
October 20, 2026

SPONSORED: KLN and Maxim’s: Growing Together for Nearly a Decade Supporting the F&B Leader’s Expansion with KLN’s Extensive Asian Network

October 19, 2026

Youibot Robotics gets CSRC approval for Hong Kong listing

RELATED ARTICLES

No related posts.

Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2026 Bamboo Works. All rights reserved.